Biotechnology Stocks
| # | Últimos 7 días | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4754 | QNRX Quoin Pharmaceuticals Ltd - American Depositary Shares | 5.33 USD | -4.31% | +7.03% | +26.90% | -42.81% | 10.70 M USD | ||
| 4755 | ASBP Aspire Biopharma Holdings, Inc. - Common Stock | 7.90 USD | -0.88% | +3.27% | +12.70% | +406.41% | 11.08 M USD | ||
| 4765 | VTGN Vistagen Therapeutics, Inc. - Common Stock | 0.24 USD | 0.00% | -7.69% | +4.35% | -53.85% | 10.65 M USD | ||
| 4767 | TOVX Theriva Biologics, Inc. Common Stock | 0.24 USD | +4.35% | +4.35% | +9.09% | -4.00% | 11.01 M USD | ||
| 4778 | SKYE Skye Bioscience, Inc. - Common Stock | 2.11 USD | +653.57% | +283.64% | +224.62% | +163.75% | 74.74 M USD | ||
| 4779 | LNAI Lunai Bioworks Inc. - Common Stock | 2.17 USD | 0.00% | -1.36% | -8.05% | +40.00% | 9.84 M USD | ||
| 4786 | MTVA MetaVia Inc. - Common Stock | 1.45 USD | -0.68% | -0.68% | -2.68% | +123.08% | 9.55 M USD | ||
| 4789 | FBLG FibroBiologics, Inc. - Common Stock | 1.38 USD | -4.17% | +23.21% | +102.94% | +126.23% | 9.19 M USD | ||
| 4790 | AEON AEON Biopharma, Inc. Class A Common Stock | 0.19 USD | 0.00% | -29.63% | -24.00% | -81.73% | 9.48 M USD | ||
| 4797 | IMNN Imunon, Inc. - Common Stock | 1.63 USD | -0.61% | 0.00% | +7.24% | -49.85% | 9.15 M USD | ||
| 4809 | CNSP CNS Pharmaceuticals, Inc. - Common Stock | 5.85 USD | -2.01% | +6.17% | +15.16% | -6.10% | 8.55 M USD | ||
| 4812 | SNGX Soligenix, Inc. - Common Stock | 0.40 USD | 0.00% | +2.56% | +8.11% | -64.60% | 8.71 M USD | ||
| 4813 | CELZ Creative Medical Technology Holdings, Inc. - Common Stock | 1.26 USD | -3.82% | +14.55% | +59.49% | -59.62% | 8.31 M USD | ||
| 4819 | XBIO Xenetic Biosciences, Inc. - Common Stock | 3.87 USD | +7.80% | +21.70% | +54.18% | +28.57% | 9.07 M USD | ||
| 4827 | TRAW Traws Pharma, Inc. - Common Stock | 0.54 USD | +1.89% | 0.00% | +10.20% | -62.24% | 8.30 M USD | ||
| 4831 | APRE Aprea Therapeutics, Inc. - Common Stock | 0.69 USD | +7.81% | 0.00% | +4.55% | -58.18% | 8.69 M USD | ||
| 4836 | ERNA Ernexa Therapeutics Inc. - Common Stock | 4.89 USD | +0.62% | +15.06% | +25.71% | +1297.14% | 7.98 M USD | ||
| 4837 | AIM AIM ImmunoTech Inc. Common Stock | 0.25 USD | -3.85% | +4.17% | 0.00% | -90.67% | 7.61 M USD | ||
| 4839 | AZTR Azitra Inc Common Stock | 0.13 USD | 0.00% | -7.14% | 0.00% | -18.75% | 7.88 M USD | ||
| 4844 | ACXP Acurx Pharmaceuticals, Inc. - Common Stock | 1.49 USD | +1.36% | -1.32% | +3.47% | -22.40% | 7.85 M USD |
Noticias Biotechnology Stocks
Deutsche Bank rebaja argenx a Mantener por valoración
¿Por qué cae hoy la acción de Monte Rosa Therapeutics?
Las acciones de Biomea Fusion se disparan tras completar el ensayo sobre diabetes
Las acciones de Monte Rosa caen al inicio de un estudio de fase 2 contra el cáncer de próstata
Las acciones de Crinetics Pharmaceuticals alcanzan máximos históricos en 84,8 dólares
H.C. Wainwright reitera su calificación de Biomea Fusion tras inscripción en ensayo
La FDA amplía la revisión de deramiocel de Capricor hasta el 22 de noviembre
Gainers Biotechnology Stocks
SKYE Skye Bioscience, Inc. - Common Stock | 2.11 | +653.57% |
RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0038 | +280.00% |
ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
NTRBW Nutriband Inc. - Warrant | 0.7500 | +50.00% |
OABIW OmniAb, Inc. - Warrant | 0.2339 | +37.59% |
LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 | +27.74% |
BMEA Biomea Fusion, Inc. - Common Stock | 1.68 | +22.63% |
CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1098 | +19.09% |
Losers Biotechnology Stocks
HUMAW Humacyte, Inc. - Warrant | 0.0050 | -44.44% |
CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
RGNX REGENXBIO Inc. - Common Stock | 8.14 | -24.07% |
ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.25 | -15.59% |
APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
BCTX BriaCell Therapeutics Corp. - Common Shares | 3.61 | -11.30% |
YDESW YD Bio Limited - Warrants | 0.3642 | -11.17% |
SNTI Senti Biosciences, Inc. - Common Stock | 0.35 | -10.26% |